Home › Funds › Empery Asset Management, LP › MSLE

Empery Asset Management, LP position in MSLE

SATELLOS BIOSCIENCE INC · Health Care

Empery Asset Management, LP reported holding 107,100 shares of MSLE (SATELLOS BIOSCIENCE INC) in its Q2 2026 13F filing — a position valued at US$833K, representing 0.96% of its reported portfolio and ranking #15 among its reported holdings. Empery Asset Management, LP has disclosed MSLE holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)107.10K sh
Reported value held$832.70K
Portfolio Weight0.96%
First reportedQ1 2026
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Empery Asset Management, LP's MSLE position evolved

Empery Asset Management, LP first disclosed a stake in MSLE in Q1 2026 at 230,100 shares (US$1.3M). Across 2 filings, Empery Asset Management, LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 107,100 shares valued at US$833K — a reduction of -123,000 shares quarter over quarter.. Notable position changes include a 53% trim in Q2 2026 (shares rose 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 230.10K $1.30M New
Q2 2026 107.10K $832.70K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MSLE and 13F data

MSLE (SATELLOS BIOSCIENCE INC) is a Health Care company. 27 other funds we track also report a position in MSLE — the largest reported positions include Vivo Capital, LLC (US$6.3M), SPHERA FUNDS MANAGEMENT LTD. (US$5.1M), Stonepine Capital Management, LLC (US$3.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MSLE

All MSLE fund holders →

FAQ

How long has Empery Asset Management, LP held MSLE?

Empery Asset Management, LP has disclosed MSLE holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Empery Asset Management, LP's current position in MSLE?

As of Q2 2026, Empery Asset Management, LP holds 107.10K shares of MSLE (SATELLOS BIOSCIENCE INC), valued at $832.70K, representing 0.96% of its reported portfolio and ranking #15.

Has Empery Asset Management, LP been buying or selling MSLE?

In the latest 13F filing (Q2 2026), Empery Asset Management, LP reduced its position in MSLE.

Which other funds hold MSLE?

Other major institutional holders of MSLE include Vivo Capital, LLC, SPHERA FUNDS MANAGEMENT LTD., Stonepine Capital Management, LLC, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.